MENU
KLTO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Klotho Neurosciences (KLTO) Ownership - Who owns Klotho Neurosciences?

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
29.04M
P/E Ratio
N/A
Total Cash
7.35M
Projected Growth
N/A
Total Debt
1.77M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.10
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

KLTO
Capitalization
29M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
7.35M
Total Cash/Share
0.10
Total Debt
1.77M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.93M
P/B Ratio
2.93
Cash Flow
N/A
Earnings
-0.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.03K
Current Ratio
83.69
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-7.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-180.10
Shares Held By Institutions
1.32M
Shares Outstanding - Current
72.5M
Total Liabilities
146K
Total Volume MTD
N/A
Value
1
Gain YTD
-12.536
View a ticker or compare two or three
KLTO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details